The primary goal of the UNC CFAR Clinical Core (Core C) is to facilitate and enhance clinical and translational HIV/AIDS research at UNC, Family Health International (FHI) and Research Triangle Institute (RTI). Core C accomplishes this goal by serving CFAR members who are established in HIV clinical and translational research and seeking out and assisting new investigators including experienced HIV basic scientists new to translational research, experienced clinical investigators new to HIV/AIDS and especially junior investigators establishing themselves in HIV research. Core C is composed of Dr. Joseph Eron (Director), Ms. Prema Menezes (Associate Core Director), Dr. Sonia Napravnik, (Epidemiologist), Dr. Christopher Pilcher (Core Investigator), Dr. Evelyn Quinlivan (Core Investigator), a part time study coordinator, two full time research assistants, one full-time clinic screener, a part time research assistant, and two part time programmers / computer specialists. Specific services offered include: assistance with design, development and conduct of clinical and translational studies including subject identification, recruitment and consent, project coordination, obtaining clinical samples, database design and management;NIH grant submission, IRB, GCRC and FDA investigational and orphan drug application support;access to the UNC CFAR HIV/AIDS Clinical Research Database (UNC CFAR-DB) and linked specimen repository including over 1700 consented participants to date;access to comprehensive data from the Clinical Socio-Demographic in-person survey including detailed behavioral information;access to the UNC Acute HIV Infection Clinical Research Program expertise and data;and access to HIV basic and clinical investigators on the three UNC CFAR campuses and from outside institutions. Core C has used these services to support a large variety of studies including HIV vaccine development (AI46023, AI50246), cellular immunology (AI20288, GM67143), the biology of HIV transmission (DK49381), acute HIV infection (MH68686), V3 (envelope) evolution (AI44667), HIV resistance (AI50845), HIV prevention (AI46749, MH69989), and antiretroviral and other HIV clinical trials (AI25868). Core C has provided leadership in HIV/AIDS Research communication by establishing a CFAR-wide local area network (LAN), the comprehensive UNC CFAR-DB and linked specimen repository, a monthly collaborative research meeting and a yearly AIDS symposium. Core C enhances training of medical and graduate students, post doctoral fellows and junior investigators as evidenced by support of student research projects, CFAR developmental awards and K-23 awards. Core C also helped establish productive collaborations with outside institutions and industry. Outreach efforts to international collaborators, and to HIV investigators, clinicians and HIV-infected individuals in the community are ongoing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-13
Application #
8080829
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
13
Fiscal Year
2010
Total Cost
$433,405
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Gausi, Blessings; Chagomerana, Maganizo B; Tang, Jennifer H et al. (2018) Human Immunodeficiency Virus Serodiscordance and Dual Contraceptive Method Use Among Human Immunodeficiency Virus-infected Men and Women in Lilongwe, Malawi. Sex Transm Dis 45:747-753
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Evon, Donna M; Stewart, Paul W; Amador, Jipcy et al. (2018) A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One 13:e0196908
Gradissimo, Ana; Lam, Jessica; Attonito, John D et al. (2018) Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women. Cancer Epidemiol Biomarkers Prev 27:1407-1415
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Price, Joan T; Mollan, Katie R; Fuseini, Nurain M et al. (2018) Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud 4:21
Cheng, Weibin; Xu, Huifang; Zhong, Fei et al. (2018) Can HIV service data be used for surveillance purposes?: a case study in Guangzhou, China. BMC Public Health 18:1268
Cole, Stephen R; Edwards, Jessie K; Westreich, Daniel et al. (2018) Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biom J 60:100-114
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266

Showing the most recent 10 out of 1688 publications